NeoMatrix HALO

Halo® Breast Pap Test for NeoMatrix (now HALO Healthcare) – An FDA approved device for non-invasive breast cancer screening. HALO is an automated system that collects nipple aspirate fluid (NAF) which is then analyzed for cellular abnormalities. It consists of a console and disposable sample collection cups. The customer (the inventor) headed a virtual company and hired Omnica to provide all services for development of the product including project management, design, fluid control, engineering, FDA documentation, prototyping, and transfer to manufacturing. We developed a unique over-molding technique for the disposable and additionally prototyped fully-operational 12 pre-production HALO devices.